This article discusses how methodological practices can shape and limit how mixed methods is practiced and makes visible the current methodological assumptions embedded in mixed methods practice that can shut down a range of social inquiry. The article argues that there is a "methodological orthodoxy" in how mixed methods is practiced…

Background: This paper discusses the Rural Center for AIDS/STD Prevention's effort to develop a web-based service called Project CREATE that responds to a need for targeted health promotion materials expressed by directors of HIV/STD prevention services in predominately rural states. Purpose: Project CREATE allows users to select customized…

The "gold standard" for evaluating human immunodeficiency virus (HIV) prevention programs is a partner-by-partner sexual behavior assessment that elicits information about each sex partner and the activities engaged in with that partner. When collection of detailed partner-by-partner data is not feasible, aggregate data (e.g., total…

Chlamydia's role in female infertility is discussed. The relationship of this organism to other diseases such as leprosy and tuberculosis is explained. Conditions caused by Chlamydia such as Pelvic Inflammatory Disease (PID) are described. (KR)

A sample of 146 African American adolescents living in impoverished neighborhoods with high HIV rates participated in the Chicago HIV Prevention and Adolescent Mental Health Project (CHAMP), a longitudinal study of adolescent HIV risk exposure. The current study examined self-reported reasons why African American adolescents may participate in…

Although a necessary component of good program management and accountability, monitoring data do not usually provide answers to questions about whether, how, and why a specific program works. More in-depth, systematic inquiry is needed to do this. In this article, the authors focus on the evaluation of human immunodeficiency virus (HIV)-prevention…

Claims that the lifetime cost of medicare per acquired immune deficiency syndrome (AIDS) patient will not exceed $80,000, an amount similar to the cost of treating other serious illnesses. Argues that the total projected costs for treating AIDS patients between 1981 and 1991 will not exceed $22 billion. (TW)

Discusses what is currently known about acquired immune deficiency syndrome (AIDS), including routes for the transmission of the AIDS virus, the prevention of AIDS, and some of the non-issues regarding the disease. Urges community leaders and teachers to become more involved in AIDS education. (TW)

Provides an overview of some major areas of legal concern in which the acquired immune deficiency syndrome (AIDS) epidemic is having an impact. Reviews rights of confidentiality and nondiscrimination regarding access to health care, employment, housing, education, and insurance. (TW)

Discusses a number of obstacles that limit effective education for reducing the incidence of acquired immune deficiency syndrome (AIDS) in the United States. Includes behaviors that must be changed, disagreement about the propriety of educational messages to prevent AIDS, and uncertainty as to some of the dual messages of reassurance being…

Discusses how the infection of the human immunodeficiency virus (HIV) results in a profound immunosuppression due predominantly to a selective depletion of helper/inducer T lymphocytes that express the receptor for the virus, as well as neuropsychiatric abnormalities in the brain. (TW)

Discusses some of the worldwide problems associated with the acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus type 1 (HIV-1). Calls for programs for the prevention and control of AIDS as an immediate priority in all countries. (TW)

Reports that by the end of 1987, nearly 50,000 cases of acquired immune deficiency syndrome (AIDS) had been reported in the United States since 1981, with 20,745 in 1987 alone. Discusses the disordinate proportion of cases involving black and Hispanic adults and children. (TW)

Discusses the complicated infection of human immunodeficiency virus type 1 (HIV-1) in its late stages of the acquired immune deficiency syndrome (AIDS) dementia complex. Explains the syndrome's development of abnormalities in cognition, motor performance, and behavior. (TW)

Poses questions about how we can control the acquired immune deficiency syndrome (AIDS) epidemic and the harm that it causes without unjustly discriminating against particular social groups and without unnecessarily infringing on the freedom of individuals. (TW)